Center-leftHigh
Ars TechnicaNews report · Nov 10, 2:43 PM
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
← Today's headlines
10 sources checked · Left, Center, and Right included · 1h ago
Different Spin
FDA adds rare vision-loss warning to popular GLP-1 drugs
Ars Technica and Al.com (Alabama News) describe the same event in different terms.
3 Left6 Center1 Right
DIFFERENT SPIN
HOW EACH SIDE WORDED IT
Left-leaningCenter-leftFDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
Ars TechnicaHigh
Right-leaningCenter-rightOzempic, Wegovy and Zepbound get new FDA warning over rare condition
Al.com (Alabama News)Mostly Factual
Center baseline · 
WJW FOX8 (Nexstar, Cleveland)HighFDA adds rare vision-loss warning to popular GLP-1 drugs
As of November 10, 2026 at 2:59 PM, this is how Optics News reads the wording differences in this story.
What happened Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday.
The headline split The left frames it as "FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss". The right frames it as "Ozempic, Wegovy and Zepbound get new FDA warning over rare condition".
Match confidence High confidence. 10 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceHigh
10 sources across Left, Center, and Right all describe the same event.
Framing confidenceModerate
74/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
Ars Technica · Center-left · News report
CenterFDA adds rare vision-loss warning to popular GLP-1 drugs
WJW FOX8 (Nexstar, Cleveland) · Center · News report
Right / center-rightOzempic, Wegovy and Zepbound get new FDA warning over rare condition
Al.com (Alabama News) · Center-right · News report
SEE THE HEADLINES
Open source
CenterHigh
WJW FOX8 (Nexstar, Cleveland)News report · Nov 10, 2:50 PM
FDA adds rare vision-loss warning to popular GLP-1 drugs
Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators an...
CenterHigh
FOX8 WGHP (Nexstar, Greensboro)News report · Nov 10, 2:59 PM
FDA requires safety label changes for GLP-1s over risk for eye condition
NAION is often called an “eye stroke” because it occurs when blood flow to the optic nerve is reduced.
Center-rightMostly Factual
Al.com (Alabama News)News report · Nov 10, 2:33 PM
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision lo...
CenterHigh
The Plain Dealer (Cleveland.com)News report · Nov 10, 2:33 PM
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision lo...
Center-leftMostly Factual
CNBCNews report · Nov 10, 2:43 PM
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
Show all 10 sources
Center-leftMostly Factual
Star LedgerNews report · Nov 10, 2:33 PM
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision lo...
CenterMostly Factual
OregonianNews report · Nov 10, 2:33 PM
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision lo...
CenterHigh
STAT NewsNews report · Nov 10, 2:38 PM
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
CenterMostly Factual
The Post-Standard (Syracuse)News report · Nov 10, 2:33 PM
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision lo...
Details74/99 Wording Gap · High confidence · 10 sources
74/99 Wording GapHigh confidence10 sources · 3 bias bucketsStable · 10 sources · all three buckets · comparable news formatFormats: News report
SOURCE MAP CHANGES
Nov 10, 2:33 PM: Al.com (Alabama News) joined the source map.
Nov 10, 2:33 PM: The Plain Dealer (Cleveland.com) joined the source map.
Nov 10, 2:33 PM: Star Ledger joined the source map.
Nov 10, 2:33 PM: Oregonian joined the source map.
Now: Wording Gap is 74/99 and story health is stable · 10 sources · all three buckets · comparable news format.